Newswise, December 8, 2015 – How fast elderly people walk may
be related to the amount of amyloid they have built up in their brains, even if
they don’t yet have symptoms of Alzheimer’s disease, according to a study
published in the December 2, 2015, online issue of Neurology®, the
medical journal of the American Academy of Neurology.
The study involved 128 people with an average age of 76 who
did not have dementia but were considered at high risk for developing it
because they had some concerns about their memory.
The participants had
positron emission tomography (PET) scans of their brains to measure amyloid
plaques in the brain. These plaques consist of dense deposits of a protein
called beta amyloid, and their progressive buildup in the brain has been
associated with the development of Alzheimer’s disease.
Of the participants, 48
percent had a level of amyloid often associated with dementia.
Participants were also tested on thinking and memory skills
and how well they could complete everyday activities. A total of 46 percent of
the participants had mild cognitive impairment, which can be a precursor to the
dementia that occurs in Alzheimer’s disease.
Walking speed was measured with a standard test that times
people on how fast they can walk about 13 feet at their usual pace. The average
walking speed was 3.48 feet per second. All but two of the participants tested
in the normal range of walking speed.
The researchers found an association between slow walking
speed and amyloid in several areas of the brain, including the putamen, a key
region involved in motor function.
The researchers compared how fast people
walked both with and without taking into account the amount of amyloid and
found that the amyloid level accounted for up to 9 percent of the difference in
walking speed.
The relationship between amyloid levels and walking speed did not
change when researchers took into account age, education level, or amount of
memory problems.
“It’s possible that having subtle walking disturbances in
addition to memory concerns may signal Alzheimer’s disease, even before people
show any clinical symptoms,” said study author Natalia del Campo, PhD, of the
Gerontopole and the Centre of Excellence in Neurodegeneration of Toulouse
(University Hospital Toulouse) in France.
Del Campo noted that the study looked only at a snapshot in
time and does not prove that amyloid plaques cause the slowdown in walking
speed; it shows the association. She also noted there are many other causes of
slow walking in older adults.
The study was based on a larger trial called the Multidomain
Alzheimer Preventive Trial, which was supported by the French Ministry of
Health and Pierre Fabre Research Institute.
The imaging was supported by Avid
Radiopharmaceuticals/Eli Lilly and Company. Biological sample collection was
supported by Exhonit Therapeutics. The promotion of the study was supported by
the University Hospital in Toulouse.
To learn more about Alzheimer’s disease, please visit www.aan.com/patients.
The American Academy of Neurology, an association of more than
28,000 neurologists and neuroscience professionals, is dedicated to promoting
the highest quality patient-centered neurologic care.
A neurologist is a doctor
with specialized training in diagnosing, treating and managing disorders of the
brain and nervous system such as Alzheimer’s disease, stroke, migraine,
multiple sclerosis, brain injury, Parkinson’s disease and epilepsy.
No comments:
Post a Comment